| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |